The regulation of GAK levels by OIP5-AS1 illustrates the dynamic impact of lncRNAs on post-transcriptional gene expression programs, including those that influence cancer and other diseases characterized by aberrant proliferation. This evidence concerns the gene OIP5 and cancer.